Methods: To determine the tumor-promoting effects of PREX2 in NSCLC, we established PREX2 knockdown NSCLC cells, then assessed cell growth in vitro and in cell-derived xenograft (CDX) mouse model. Here, PREX2 is linked to non-small cell lung carcinoma.